Platinum‐Based TREM2 Inhibitor Suppresses Tumors by Remodeling the Immunosuppressive Microenvironment
Angewandte Chemie International Edition · 09.01.2023 · 62 (2)
DOI: 10.1002/anie.202213337 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 07.12.2022. Verfasst von Tao Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210023, P. R. China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Colonic Neoplasms. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Triggering receptor expressed on myeloid cells‐2 (TREM2) is a key pro‐tumorigenic marker of tumor‐infiltrating macrophages, showing potent immunosuppressive activity in tumor microenvironment. A platinum(IV) complex OPA derived from oxaliplatin (OP) and artesunate (ART) exhibited direct cytotoxicity against human colon cancer cells and immunomodulatory activity to inhibit TREM2 on macrophages in vitro and vivo. Furthermore, OPA deterred the tumor growth in mouse models bearing MC38 colorectal tumor by reducing the number of CD206 + and CX 3 CR1 + immunosuppressive macrophages; it also promoted the expansion and infiltration of immunostimulatory dendritic, cytotoxic T, and natural killer cells. OPA is the first small‐molecular TREM2 inhibitor capable of relieving immunosuppressive tumor microenvironment and enhancing chemical anticancer efficiency of a platinum drug, thus showing typical characteristics of a chemoimmunotherapeutic agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210023, P. R. China.
- Chemistry and Biomedicine Innovation Center, Nanjing University, Nanjing, 210023, P. R. China.
- State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, 210023, P. R. China.
- Institute of Chemical Biology and Functional Molecules, State Key Laboratory of Materials-Oriented Chemical Engineering, School of Chemistry and Molecular Engineering, Nanjing Tech University, Nanjing, 211816, P. R. Chi…
ORCID-Profile: Xiaoyong Wang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- China Postdoctoral Science Foundation
Zitieren
APA
Yang, T., Zhang, S., Yuan, H., Wang, Y., Cai, L., Chen, H., Wang, X., Song, D., Wang, X., Guo, Z., & Wang, X. (2023). Platinum‐Based TREM2 Inhibitor Suppresses Tumors by Remodeling the Immunosuppressive Microenvironment. Angewandte Chemie International Edition, 62(2). https://doi.org/10.1002/anie.202213337
Vancouver
Yang T, Zhang S, Yuan H, Wang Y, Cai L, Chen H, et al. Platinum‐Based TREM2 Inhibitor Suppresses Tumors by Remodeling the Immunosuppressive Microenvironment. Angewandte Chemie International Edition. 2023;62(2). doi:10.1002/anie.202213337
BibTeX
@article{Yang2023,
author = {Yang, Tao and Zhang, Shuren and Yuan, Hao and Wang, Ying and Cai, Linxiang and Chen, Hanhua and Wang, Xiaoyu and Song, Dongfan and Wang, Xiaohui and Guo, Zijian and Wang, Xiaoyong},
title = {Platinum‐Based TREM2 Inhibitor Suppresses Tumors by Remodeling the Immunosuppressive Microenvironment},
journal = {Angewandte Chemie International Edition},
year = {2023},
volume = {62},
number = {2},
doi = {10.1002/anie.202213337}
}
EUVIMED